Aventis Pharma today said that its net profit declined by 9.97 per cent to Rs 42.4 crore for the second quarter ended June 30, compared to the same period in the previous fiscal.
Net sales of the company rose to Rs 271.5 crore for the second quarter ended June 30, compared to Rs 249.9 crore in the same period of the corresponding fiscal, Aventis Pharma said in a filing to the Bombay Stock Exchange (BSE).
Besides this, the company's board has recommended an interim dividend of Rs 4 per equity share of Rs 10.
For the six months ended June 30, the company reported a net profit of Rs 78.5 crore, compared to Rs 87.6 crore in the same period of the corresponding fiscal.
Net sales of the company increased to Rs 522.9 crore for the six months ended June 30, compared to Rs 478.8 crore in the same period in the last fiscal.
Shares of Aventis Pharma today closed at Rs 1,973.25 on the BSE, down 1.33 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
